Ultrasound‐Guided Vacuum‐Assisted Excision to Treat Intraductal Papilloma

Abstract

Background To evaluate the value of ultrasound‐guided vacuum‐assisted excision (US‐guided VAE) in the treatment of intraductal papillomas, including intraductal papillomas with atypical ductal hyperplasia (ADH), and to evaluate the lesion characteristic features affecting the local recurrence rate. Materials and methods Between August 2011 and December 2020, 91 lesions of 91 patients underwent US‐guided VAE and were diagnosed with intraductal papilloma with or without ADH. The recurrence rate of intraductal papilloma was evaluated on follow‐up US. The lesion characteristic features were analyzed to identify the factors affecting the local recurrence rate. Results The local recurrence rate of intraductal papillomas removed by US‐guided VAE was 7.7% (7/91), with the follow‐up duration 12–92 months (37.4 ± 23.9 months). Of the 91 patients, five cases diagnosed as intraductal papilloma with ADH did not recur, with the follow‐up time 12–47 months (26.4 ± 14.4 months). There were no malignant transformation in all 91 cases during the follow‐up period. All 7 patients recurred 7–58 months (22.8 ± 19.2 months) after US‐guided VAE. There were no significant differences between the non‐recurrence and recurrence groups in terms of age, side, distance from nipple, lesion size, BI‐RADS category, with ADH, or history of excision (p > 0.05). Conclusions US‐guided VAE is an effective method for the treatment of intraductal papilloma, including intraductal papilloma with ADH. It avoids invasive surgical excision, but regular follow‐up is recommended to prevent recurrence or new onset due to multifocality. Any suspicious lesions during the follow‐up should be actively treated.